ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BEAM Beam Therapeutics Inc

24.03
-0.29 (-1.19%)
May 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 642,085
Bid Price 23.81
Ask Price 24.65
News -
Day High 24.54

Low
16.95

52 Week Range

High
49.50

Day Low 23.625
Company Name Stock Ticker Symbol Market Type
Beam Therapeutics Inc BEAM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.29 -1.19% 24.03 20:00:00
Open Price Low Price High Price Close Price Prev Close
24.54 23.625 24.54 24.22 24.32
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,663 642,085 $ 24.10 $ 15,475,497 - 16.95 - 49.50
Last Trade Time Type Quantity Stock Price Currency
17:18:52 formt 300 $ 24.03 USD

Beam Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.98B 81.66M - 377.71M -132.53M -1.62 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Beam Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BEAM Message Board. Create One! See More Posts on BEAM Message Board See More Message Board Posts

Historical BEAM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week24.7125.5823.62524.56803,595-0.68-2.75%
1 Month21.5626.1521.0123.171,103,2592.4711.46%
3 Months37.1340.08520.8427.661,301,103-13.10-35.28%
6 Months29.1049.5020.8429.261,371,560-5.07-17.42%
1 Year32.8049.5016.9527.791,207,753-8.77-26.74%
3 Years80.00138.521916.9546.241,027,675-55.97-69.96%
5 Years19.19138.521913.0049.42918,0504.8425.22%

Beam Therapeutics Description

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Your Recent History

Delayed Upgrade Clock